Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was conducted to investigate the effects of the intake of deep sea water prior to resistance training on blood pressure, oxidative stress and hepatic and renal variables in older women.
This study was a 32 weeks, double-blinded, randomized, placebo-controlled trial.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Resistance training + deep sea water | Experimental | Resistance training with elastic bands prior intake of deep sea water (20ml) twice weekly during 32 weeks. |
|
| Resistance training + Placebo | Active Comparator | Resistance training with elastic bands prior placebo water (20ml) twice weekly during 32 weeks. |
|
| Control + Deep sea water | Active Comparator | No exercise and intake of deep sea water (20ml) twice weekly during 32 weeks. |
|
| Control + Placebo | Placebo Comparator | No exercise and intake of placebo water (20ml) twice weekly during 32 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Resistance training + deep sea water | Dietary Supplement | A group that will perform a resistance training protocol with variable resistance and at the same time will receive a supplementation composed by deep sea water |
| Measure | Description | Time Frame |
|---|---|---|
| Malondialdehyde (MDA) | Oxidative stress biomarker | pre (week 0) and post (week 32) |
| Oxidized/reduced glutathione ratio (GSH/GSSG) | Antioxidant enzyme | pre (week 0) and post (week 32) |
| Interleukin-6 (IL-6) | Inflammatory biomarker | pre (week 0) and post (week 32) |
| Vitamin D | Vitamin | pre (week 0) and post (week 32) |
| Measure | Description | Time Frame |
|---|---|---|
| Glutamic-oxaloacetic transaminase (GOT) | Hepatic biomarker | pre (week 0) and post (week 32) |
| Glutamic-pyruvic transaminase (GPT) | Hepatic biomarker |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Participants who had suffered:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Resistance training + Placebo | Dietary Supplement | A group that will perform a resistance training protocol with variable resistance and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation |
|
| Control + deep sea water | Dietary Supplement | A group that will maintain their usual live and at the same time will receive a supplementation composed by deep sea water |
|
| Control + Placebo | Dietary Supplement | A group that will maintain their usual live and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation |
|
| pre (week 0) and post (week 32) |
| Gamma- glutamyl transpeptidase (GGT) | Hepatic biomarker | pre (week 0) and post (week 32) |
| Alkaline phosphatase enzyme (ALP) | Hepatic biomarker | pre (week 0) and post (week 32) |
| Systolic blood pressure (SBP) | Cardiovascular measure | pre (week 0) and post (week 32) |
| Diastolic blood pressure (SBP) | Cardiovascular measure | pre (week 0) and post (week 32) |
| Up and Go test (UGT) | Functional test | pre (week 0) and post (week 32) |
| Age | Sample demographic description | pre (week 0) and post (week 32) |
| Height | Sample demographic description | pre (week 0) and post (week 32) |
| Weight | Sample demographic description | pre (week 0) and post (week 32) |
| Body mass index (BMI) | Sample demographic description | pre (week 0) and post (week 32) |
| Fat mass percentage (% fat mass) | Sample demographic description | pre (week 0) and post (week 32) |
| ID | Term |
|---|---|
| D007674 | Kidney Diseases |
| ID | Term |
|---|---|
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D055070 | Resistance Training |
| ID | Term |
|---|---|
| D005081 | Exercise Therapy |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided